Table 3.
The modified Downs and Black: assessment of the methodological quality
| Study | 1. Hypothesis/aim/objective clearly described | 2. Main outcomes clearly described | 3. Characteristics of patients clearly described |
5. Confounders clearly described, matched, adjusted |
7. Estimates of the random variability for the main outcomes | 10. Probability values reported | 11. Were the subjects asked to participate representative of the entire population? | 12. Were the subjects prepared to participate representative of the entire population? | 15. Blindness of assessors | 16. Clear data dredging |
| [30] [34] | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 |
| [29] [33] | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| [28] [32] | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 |
| [12] [14] | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 |
| Study | 18. Appropiate statistical tests |
20. Accurate outcome measures |
21. Cases & controls recruited from the same population | 22. Cases & controls recruited from the same period |
25. Adequate adjustment for confounding |
26. Losses to follow-up considered |
27. Sufficient power to detect a clinically important effect |
Rate |
Percentage (%) |
Quality |
| [30] [34] | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 10 | 56 | M |
| [29] [33] | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 15 | 83 | H |
| [28] [32] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 14 | 78 | H |
| [12] [14] | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 11 | 61 | M |
Abbreviations: M moderate, H high